Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global immunoglobulin market size reached US$ 13.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.34% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.
Immunoglobulin Market Trends:
Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and mode of delivery.
Breakup by Product:
IgG
IgA
IgM
IgE
IgD
Breakup by Application:
Hypogammaglobulinemia
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunodeficiency Disease
Myasthenia Gravis
Others
Breakup by Mode of Delivery:
Intravenous Mode of Delivery
Subcutaneous Mode of Delivery
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global immunoglobulin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunoglobulin market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the mode of delivery?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunoglobulin market and who are the key players?
What is the degree of competition in the industry?
Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.
Immunoglobulin Market Trends:
Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases. As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and mode of delivery.
Breakup by Product:
IgG
IgA
IgM
IgE
IgD
Breakup by Application:
Hypogammaglobulinemia
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunodeficiency Disease
Myasthenia Gravis
Others
Breakup by Mode of Delivery:
Intravenous Mode of Delivery
Subcutaneous Mode of Delivery
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.
Key Questions Answered in This Report:
How has the global immunoglobulin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global immunoglobulin market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the mode of delivery?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global immunoglobulin market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IMMUNOGLOBULIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 IgG
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 IgA
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 IgM
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 IgE
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 IgD
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Hypogammaglobulinemia
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunodeficiency Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Myasthenia Gravis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY MODE OF DELIVERY
8.1 Intravenous Mode of Delivery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Subcutaneous Mode of Delivery
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ADMA Biologics Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Baxter international Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biotest AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 CSL Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Grifols S.A
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Kedrion S.p.A
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 LFB SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Octapharma AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Sanquin Plasma Products B.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL IMMUNOGLOBULIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 IgG
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 IgA
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 IgM
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 IgE
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 IgD
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Hypogammaglobulinemia
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunodeficiency Disease
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Myasthenia Gravis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY MODE OF DELIVERY
8.1 Intravenous Mode of Delivery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Subcutaneous Mode of Delivery
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ADMA Biologics Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Baxter international Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biotest AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 CSL Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Grifols S.A
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Kedrion S.p.A
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 LFB SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Octapharma AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Sanquin Plasma Products B.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2022-2027
Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Immunoglobulin Market: Competitive Structure
Table 7: Global: Immunoglobulin Market: Key Players
Table 1: Global: Immunoglobulin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Immunoglobulin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Immunoglobulin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Immunoglobulin Market Forecast: Breakup by Mode of Delivery (in Million US$), 2022-2027
Table 5: Global: Immunoglobulin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Immunoglobulin Market: Competitive Structure
Table 7: Global: Immunoglobulin Market: Key Players
LIST OF FIGURES
Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2021
Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2021
Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2021
Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2021
Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis
Figure 1: Global: Immunoglobulin Market: Major Drivers and Challenges
Figure 2: Global: Immunoglobulin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Immunoglobulin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Immunoglobulin Market: Breakup by Product (in %), 2021
Figure 5: Global: Immunoglobulin Market: Breakup by Application (in %), 2021
Figure 6: Global: Immunoglobulin Market: Breakup by Mode of Delivery (in %), 2021
Figure 7: Global: Immunoglobulin Market: Breakup by Region (in %), 2021
Figure 8: Global: Immunoglobulin (IgG) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Immunoglobulin (IgG) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Immunoglobulin (IgA) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Immunoglobulin (IgA) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Immunoglobulin (IgM) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Immunoglobulin (IgM) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Immunoglobulin (IgE) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Immunoglobulin (IgE) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Immunoglobulin (IgD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Immunoglobulin (IgD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Immunoglobulin (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Immunoglobulin (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Immunoglobulin (Chronic Inflammatory Demyelinating Polyneuropathy-CIDP) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Immunoglobulin (Immunodeficiency Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Immunoglobulin (Immunodeficiency Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Immunoglobulin (Myasthenia Gravis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Immunoglobulin (Myasthenia Gravis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Immunoglobulin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Immunoglobulin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Immunoglobulin (Intravenous Mode of Delivery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Immunoglobulin (Intravenous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Immunoglobulin (Subcutaneous Mode of Delivery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Immunoglobulin Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Immunoglobulin Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Immunoglobulin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Immunoglobulin Industry: SWOT Analysis
Figure 82: Global: Immunoglobulin Industry: Value Chain Analysis
Figure 83: Global: Immunoglobulin Industry: Porter's Five Forces Analysis
